Air India has announced a comprehensive initiative to subject its entire pilot workforce to mandatory substance testing. This move follows a concerning mid-air incident on August 4, where an Airbus flight traveling from Phuket to Delhi experienced a sudden altitude drop of approximately 300 feet shortly after takeoff. The event resulted in injuries to 17 passengers and crew members, prompting an immediate investigation by Indian authorities in collaboration with Airbus and French aviation safety regulators.

Preliminary reports regarding the Phuket-Delhi flight suggest that a senior pilot involved in the incident may have tested positive for marijuana, leading to the suspension of both pilots pending the conclusion of the investigation. In response, Air India is expanding its testing protocols beyond the standard regulatory requirement, which previously mandated random testing for only 10% of flight crews. The new policy, which also extends to the airline’s budget subsidiary, Air India Express, aims to ensure strict adherence to aviation safety standards regarding both illicit substances and prohibited medications.

These enhanced safety measures are being rolled out across various operational hubs, including training academies, briefing centers, and corporate offices. The airline stated that this proactive approach is intended to reinforce professionalism and restore public confidence following a series of high-profile safety challenges. The carrier has faced intense scrutiny recently, particularly following a tragic crash in June 2025 involving a flight from Ahmedabad to London, which resulted in significant loss of life. As the airline navigates these operational hurdles, the new leadership is prioritizing safety protocols to mitigate further risks.

Key Takeaways

• Air India is mandating substance testing for all pilots, exceeding current regulatory requirements.
• The decision follows a mid-air altitude loss incident on an August 4 flight that left 17 people injured.
• Both pilots involved in the recent Phuket-Delhi flight have been suspended while investigations continue.

Editor’s Analysis & Impact

The decision by Air India to implement universal substance testing marks a critical pivot in its operational strategy as it attempts to recover from a series of catastrophic safety failures. By moving beyond the industry-standard 10% random testing threshold, the airline is attempting to signal a ‘safety-first’ culture to both regulators and the traveling public. However, the broader implications suggest a deeper systemic struggle within the carrier, particularly following the 2025 Ahmedabad-London crash. The airline’s ability to regain market trust will depend heavily on the efficacy of these new internal controls and the leadership’s capacity to overhaul safety management systems. If successful, this could set a new benchmark for regional aviation safety; if not, the airline risks further regulatory intervention and a continued decline in passenger confidence.

Frequently Asked Questions

Q: Why is Air India increasing its pilot testing protocols?
A: The airline is increasing testing to enhance safety standards and restore public trust following a recent mid-air incident where a flight lost altitude, causing injuries to passengers and crew.

Q: Does this new policy apply to all Air India pilots?
A: Yes, the new testing initiative covers the entire pilot workforce at Air India, as well as pilots working for its budget subsidiary, Air India Express.